Wilco raises EUR 2.5m for AI agents that keep clinic patients from slipping away
The startup works with Spanish groups such as Vitaldent, Clínica Baviera and WM Clinics and plans to expand into the rest of Europe, the United States and Latin America.

Wilco, a Madrid-based startup building AI voice and messaging agents for healthcare clinic groups, has raised EUR 2.5 million in a round led by Samaipata, Cinco Días and Europa Press reported on 19 November. ABAC Nest Ventures, the venture capital arm of Abac Capital, and executives from the technology and healthcare sectors also took part.
Founded by Spanish entrepreneur Francisco Hernández Parga, who is chief executive, Wilco will use the money to strengthen its engineering, deployment and sales teams and to expand into the rest of Europe, the United States and Latin America.
The problem it targets
Clinics are spending more and more to attract patients, but between 60 and 80 percent of enquiries are lost before they reach a consultation, according to the company. They end up as unreturned calls, unconfirmed appointments, no-shows and quotes that stall with the patient saying they need to think about it. In some cases no-shows affect half of all first visits, Wilco told Cinco Días.
Wilco's AI agents are built to cover exactly that stretch. They call, message and follow up with patients by phone and WhatsApp, from the first enquiry through to a signed treatment plan and a return visit, EU-Startups reported. The platform covers four stages: reaching every new lead, making sure patients attend their appointment, helping them accept a treatment plan and bringing them back for follow-up care.
People stay in the loop
If a patient prefers to speak to a person, the conversation is passed to the clinic's team, and clinical questions always go to healthcare professionals, who decide on treatment, the company told Cinco Días. Wilco says it measures itself not by the calls it handles but by the visits and accepted treatments recorded by each clinic.
To set up each deployment, Wilco uses forward-deployed engineers who work with a clinic's operations and IT leads to build, test and launch workflows before any real patient interaction. Clients typically go live within three to eight weeks, depending on how the system has to connect with the clinic's management software, and the engineers stay involved after launch to refine the workflows, according to EU-Startups.
Customers
Wilco serves clinics across six specialities: dental, medical aesthetics, veterinary, physiotherapy, ophthalmology and dermatology. Its clients include some of the largest clinic groups in Spain, among them Vitaldent, Clínica Baviera and WM Clinics. The company says one client has used Wilco to reactivate dormant patients and that this could generate more than EUR 40 million in economic impact; that figure is the company's own estimate and has not been independently verified.
"Around artificial intelligence there is a lot of noise, but the problem for clinics is that they invest in attracting the patient and, too often, they lose them before they reach the consultation. Our job is to make sure that patient opens the door and accepts their treatment plan," said Hernández Parga (quote translated from Spanish).
The investors
"Wilco is exactly the type of company we look for with our third fund: artificial intelligence applied to a very specific problem in a vertical, with a return that the client sees directly in its business," said Íñigo Laucirica, partner at Samaipata (quote translated from Spanish).
Samaipata has more than EUR 200 million in assets under management across three funds, and its third fund focuses on AI-native companies, according to Cinco Días. Since its founding in 2016 it has invested in 45 European companies, including Matera, Deporvillage, Embat, Bigblue and Nory.
The company also has a view on where the market is going. "Today the patient calls the clinic. Soon their AI agent will. We are building for that," Wilco said in a LinkedIn post quoted by EU-Startups.
Why it matters
AI voice agents for healthcare front desks are a busy field, and Wilco does not claim to be the first. Its approach is to sell outcomes, meaning attended visits and accepted treatment plans, to large multi-site clinic groups, and to pair the software with engineers embedded at each client. That model is closer to services than to pure software: it can help adoption, but it requires more people on the ground as the company expands into new countries.
For European healthtech founders, the round shows that seed investors are backing narrow, measurable use cases inside private healthcare rather than broad AI platforms. Another Spanish AI startup, Fermat, raised its seed round this week, and camera-based health monitoring startup IntelliProve also announced funding recently. More AI coverage is in our AI and tech section.
Spotted an error? Email contact@europreneursmedia.com and we'll correct it. See our corrections policy and editorial standards.


